Among the sessions of the ACO & Emerging Healthcare Delivery Coalition Spring 2017 meeting was a panel discussion on population health strategies. According to Sachin H. Jain, MD, MBA, president and CEO of CareMore, the discussion was optimistic about the future of the healthcare system, particularly due to the new therapies and technologies that are being developed.
Among the sessions of the ACO & Emerging Healthcare Delivery Coalition Spring 2017 meeting was a panel discussion on population health strategies. According to Sachin H. Jain, MD, MBA, president and CEO of CareMore, the discussion was optimistic about the future of the healthcare system, particularly due to the new therapies and technologies that are being developed.
Transcript (slightly modified)
What is one key takeaway from the panel discussion on population health strategies at the ACO & Emerging Healthcare Delivery Coalition?
I would say the one key takeaway is that the future of healthcare is an uncertainty right now, and I think that there’s going to be lots of progress along lots of different dimensions. I think we’re going to have new therapies, new drugs that are going to solve problems that we previously thought were insolvable. We’re going to have new technologies. I think we’re going to have a broader view of the patient in their social context.
I think the real takeaway from that panel is a lot of optimism, actually, that there’s a group of people out there who are actually trying to solve the problems that patients have in 2017. The healthcare system of the future, 2025, 2030, whatever your future look is, is going to be that we are taking better care of our patients.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen